PK / ADA Analysis for Biologics Development
PK (pharmacokinetic) analysis measures how much of a biologic drug remains in the body over time, while ADA (anti-drug antibody) analysis evaluates immune responses generated against the therapeutic.
These analyses are important for biologics, biosimilars, and antibody-based drug development, supporting immunogenicity assessment, comparability studies, and bioanalytical decision-making.
R&D Mate provides access to ELISA kits, anti-idiotype antibodies, and related assay solutions for PK / ADA workflows, with the potential to extend into technical review, custom assay discussion, and CRO-based analytical support.